UNCOVERED: Value line - Caught on Camera

Strong Revenue and Income Growth Make Proto Labs Stock the ‘Real Deal’

Proto Labs (PRLB) demonstrates strong technical momentum with shares trading at a new 5-year high. The stock has gained more than 90% over the past 52 weeks. Analyst sentiment is mixed. Barchart rates it a “Strong Buy” while CFRA rates it a “Sell.” Despite its elevated valuation, consistent price appreciation...

Barchart · Sep 30

RingCentral Stock Looks Like a Winner at New 3-Year Highs

RingCentral (RNG) demonstrates strong technical momentum, recently hitting a 3-year high. Shares are up more than 140% over the past year. RNG maintains a 100% “Buy” technical opinion from Barchart. Despite high price momentum, consistent revenue, income, and cash flow growth support a solid outlook. Today’s Featured Stock Valued at...

Barchart · Sep 29

This Little-Known Stock Has Surged 550% in the Past Year

SELLAS Life Sciences (SLS) has surged 550% in the past year, driven by technical momentum and speculative trading. SLS currently has no revenue, with all products in development or clinical trials, making the stock highly speculative. Technical indicators are overwhelmingly bullish, but high short interest highlights significant risk. Sentiment is...

Barchart · Jul 6

Slow and Steady Wins The Race

Summary The Travelers Companies (TRV) demonstrates strong technical momentum, with a Trend Seeker 'Buy' signal and 9.54% gain over the past month. TRV trades at an 11.01x trailing P/E, notably below the Value Line average of 19.50, suggesting valuation remains attractive despite recent price highs. Revenue is projected to grow...

Barchart · Feb 28

Short Sellers Are Betting Against Lumentum Stock. Will They Be Proven Right?

Lumentum (LITE) has surged 340% over the past year, driven by strong technical momentum. The stock recently set a new 10-year high. Shares maintain a 100% “Buy” opinion from Barchart. Analyst sentiment is bullish, with most rating LITE a “Strong Buy” although price targets vary widely. Today’s Featured Stock Valued...

Barchart · Dec 29, 2025

This Undiscovered Stock Could Handsomely Reward Risk Takers

Seaboard (SEB) exhibits exceptional technical momentum, gaining 80% over the past year and recently hitting new all-time highs. SEB maintains a 100% “Buy” technical opinion from Barchart. Despite limited Wall Street coverage, SEB is rated “Above Average” by Value Line and a “Buy” by CFRA. SEB’s appeals to risk-tolerant investors...

Barchart · Dec 2, 2025

Why I Trust These Trillion-Dollar Stocks

The top-heavy nature of the S&P 500 should make any investor nervous, but there's still plenty to like in these trillion-dollar stocks.

Kiplinger · Nov 28, 2025

This Stock Has Technical Strength and a High Dividend Yield, But Red Flags Are Waving

Kenon Holdings (KEN) is trading at a new three-year high and has strong technical momentum. KEN has surged 94% over the past year and offers a 8.54% dividend. Shares have a 100% “Buy” opinion from Barchart. Despite the technical strength, Wall Street sentiment is lukewarm. Extreme caution and disciplined risk...

Barchart · Nov 11, 2025

This ‘Strong Buy’ Healthcare Stock Just Hit New All-Time Highs

McKesson (MCK) is trading at new all-time highs and has strong technical momentum. MCK has a 100% “Buy” opinion from Barchart. Shares are up nearly 60% over the past year. Analyst sentiment is overwhelmingly positive, with multiple “Strong Buy” ratings and price targets up to $984, despite some valuation concerns....

Barchart · Oct 28, 2025

This ‘Strong Buy’ Stock Is Trading at New 20-Year Highs

Insmed (INSM) is a biopharmaceutical company with strong momentum. Shares are trading at new 20-year highs. INSM has surged 128% over the past year. Analysts expect robust revenue and earnings growth, but opinions are mixed, with some cautioning the stock is overvalued. Today’s Featured Stock Valued at $34.3 billion, Insmed...

Barchart · Oct 8, 2025